Press Releases

Singlera Genomics raises $150 million in Series B financing to promote the development and commercialization of early cancer screening products

Dec. 15, 2020 Singlera Genomics Inc. today announced that it raised $150 million in Series B financing. This round of financing was led by the CICC Kai Tak Innovative Biomedicine Fund, and co-led by Detong Capital and Furong Investment. The new group of investors also include Huamei International, Linden Asset Group, Wuxi Capital, FutureX Skyline Capital, Shanghai Free Trade Zone Fund, and initial investors from the Series A round such as Greenpine Capital, Prosperico Ventures, and Proxima Ventures joined with follow-on investment.

Singlera Genomics and Fudan University unveiled results demonstrating detection of five common cancers earlier than standard test

July 21, 2020 Fudan University's Taizhou Health Science Institute and Singlera Genomics, focused on non-invasive early cancer detection, today announce the publication of a peer reviewed manuscript demonstrating the initial results from the Taizhou Longitudinal Study (TLS), showing Singlera's PanSeer assay can detect five types of cancer up to four years before conventional diagnosis with a single blood draw.

Singlera Genomics Meets with FDA for Rapid Colon Cancer Assay and Has a Clear Path Forward

May 11, 2020 Singlera Genomics completed their second Pre-Submission Meeting with the US FDA Center for Devices and Radiological Health, Office of In Vitro Diagnostics on April 21, 2020, after an initial Pre-Submission Meeting in the fall of 2019. The FDA provided clear guidance on the regulatory pathway and clinical trial plan for Singlera Genomics ColonES assay.

Singlera Genomics and Fudan University unveil results showing Pan-Cancer Early Detection in the Taizhou Longitudinal Study

October 18, 2018 Fudan University's Taizhou Health Science Institute and Singlera Genomics, a UC San Diego spinout company focused on non-invasive early cancer detection, today announce initial results from the Taizhou Longitudinal Study (TLS) during the 2018 American Society of Human Genetics

Singlera Genomics unveils results of ColonES study demonstrating detection of advanced adenoma and colorectal cancer

October 18, 2018 In collaboration with Fudan University Shanghai Cancer Center and Nanfang Hospital of Southern Medical University, Singlera Genomics, a UC San Diego spinout company focused on non-invasive cancer detection, presented...

Singlera Genomics Raises $60 Million in Series A+ Financing

March 27, 2018 Singlera Genomics, a non-invasive genetic diagnostics company that focuses on early-stage cancer detection, today announced that it has successfully...

Singlera Genomics Raises $20 Million In Series A Financing Led by Lilly Asia Ventures

August 22, 2016 Singlera Genomics, a fast-growing, non-invasive genetic testing company, today announced it has successfully raised US$20 million in a Series A...

Singlera Genomics, Fudan University Collaborate on Longitudinal Study of 200,000 Volunteer Cohort

July 18, 2016 On June 28, 2016, Taizhou Institute of Health Sciences of Fudan University and Singlera Genomics Inc. signed a strategic agreement in Taizhou City...

Publications of note

  1. Chen X. et al Nat Comm. 2020 Non-invasive early detection of cancer four years before conventional diagnosis using a blood test. doi: 10.1038/s41467-020-17316-z
  2. Guo S. et al Nat Genet. 2017 Identification of methylation haplotype blocks aids in deconvolution of heterogeneous tissue samples and tumor tissue-of-origin mapping from plasma DNA. doi: 10.1038/ng.3805
  3. BLUEPRINT consortium. Nat Biotechnol. 2016 Quantitative comparison of DNA methylation assays for
    biomarker development and clinical applications. doi: 10.1038/nbt.3605
  4. Gole J. et al Nat Biotechnol. 2013 Massively parallel polymerase cloning and genome sequencing of
    single cells using nanoliter microwells. doi: 10.1038/nbt.2720
  5. Ruiz S. et al. Proc Natl Acad Sci U S A. 2012 Identification of a specific reprogramming-associated epigenetic signature in human induced pluripotent stem cells. doi: 10.1073/pnas.1202352109
  6. Diep D. et al Nature Meth 2012 Library-free methylation sequencing with bisulfite padlock probes. doi: 10.1038/nmeth.1871
  7. Yamaguchi S. et al Nature 2012 Tet1 controls meiosis by regulating meiotic gene expression https://www.ncbi.nlm.nih.gov/pubmed/23151479
  8. Gore A. et al Nature 2011 Somatic coding mutations in human induced pluripotent stem cells. doi: 10.1038/nature09805
  9. Shoemaker R. et al. Genome Res. 2010. Allele-specific methylation is prevalent and is contributed by CpG-SNPs in the human genome. doi: 10.1101/gr.104695.109
  10. Deng J. et al. Nat Biotechnol. 2009. Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. doi: 10.1038/nbt.1530

Discover The Future

At the leading edge of biology and assay technology, Singlera Genomics uses a new biomarker type called ctmDNA (circulating tumor methylated DNA) to peer into the future.

Contact Us
Email Signup